BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:bivamelagon readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of bivamelagon\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07156578-216@assetmemo.bio
DTSTAMP:20261121T005611Z
DTSTART;VALUE=DATE:20280415
DTEND;VALUE=DATE:20280416
SUMMARY:bivamelagon: Phase 2 readout est. (NCT07156578)
DESCRIPTION:bivamelagon\, phase 2\, Hypothalamic Obesity.\nStudy: A Long-Te
 rm Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)\nEs
 timated primary completion: 15 April 2028. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/bivamelagon#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT07156578
URL:https://assetmemo.bio/drug/bivamelagon#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
